FDA ApprovalsRegulatory US Regulators Approve First-of-Its-Kind Hepatitis B Treatment from GSK and Ionis October 22, 2026 antiviral therapy, bepirovirsen, hepatitis b
FDA ApprovalsRegulatory FDA Approves Bepirovirsen as Potential Functional Cure for Chronic Hepatitis B October 21, 2026 antiviral therapy, bepirovirsen, hepatitis b
